An IGHG1 变异体表现出极化分布并增强对致命病原体的 IgG1 抗体反应
Author Correction: An IGHG1 variant exhibits polarized prevalence and confers enhanced IgG1 antibody responses against life-threatening organisms
Nature Immunology 发表了对先前文章的更正,修正了 Source Data 中的标签和组织错误,并更新了相关图表。修正后的 Source Data 和图表现已发布,供读者参考。
Correction to: Nature Immunology https://doi.org/10.1038/s41590-024-01944-4, published online 11 September 2024.
In the version of this article initially published, there were labeling and organizational errors in the Source Data for Figs. 2j and 4f, g, k, and data not used in the published article was inadvertently included. Source Data for Figs. 4d, h, l, Extended Data Fig. 1d, i and their associated figure panels presented results from incorrect datasets. The Source Data and figures are now updated in the HTML and PDF versions of the article. For comparison, the original and corrected figures are available as Supplementary Information accompanying this amendment.
Author information
Author notes
These authors contributed equally: Wenbo Sun, Tingyu Yang, Fengming Sun, Panhong Liu, Ji Gao, Xianmei Lan, Wei Xu.
Authors and Affiliations
School of Life Sciences, Institute for Immunology, State Key Laboratory of Membrane Biology, China Ministry of Education Key Laboratory of Protein Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China
Wenbo Sun, Ji Gao, Tong Li, Cuifeng Li, Xiaohang Liu & Wanli Liu
Tsinghua-Peking Center for Life Sciences, Beijing, China
Wenbo Sun, Tingyu Yang, Tong Li, Cuifeng Li, Yanyi Huang & Wanli Liu
Biomedical Pioneering Innovation Center (BIOPIC), Beijing Advanced Innovation Center for Genomics (ICG), Peking University, Beijing, China
Tingyu Yang, Yuhong Pang & Yanyi Huang
Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
Fengming Sun, Wenting Tan & Guohong Deng
Chongqing Key Laboratory for Research of Infectious Diseases, Chongqing, China
Fengming Sun & Guohong Deng
Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, China
Fengming Sun
BGI-Shenzhen, Shenzhen, China
Panhong Liu, Xianmei Lan, Huanhuan Zhu & Xin Jin
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China
Xianmei Lan
Key Laboratory of Medical Molecular Virology of MOE/NHC/CAMS, School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Fudan University, Shanghai, China
Wei Xu & Lu Lu
NexVac Research Center, Center for Infectious Disease Research, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China
Qingtai Liang, Haoze Chen, Jingren Zhang & Linqi Zhang
The Third People’s Hospital of Shenzhen, National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China
Fang Wang
Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Fanjun Cheng
Key Laboratory of Zoological Systematics and Evolution, Institute of Zoology, Chinese Academy of Sciences, Beijing, China
Weiwei Zhai
Center for Excellence in Animal Evolution and Genetics, Chinese Academy of Sciences, Kunming, China
Weiwei Zhai
Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea
Han-Na Kim
Biomedical Statistics Center Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea
Han-Na Kim
Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, China
Linqi Zhang
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China
Linqi Zhang
Key Laboratory of Protein Sciences (Ministry of Education), State Key Laboratory of Molecular Oncology, School of Life Sciences, Tsinghua University, Beijing, China
Qiaoran Xi
College of Chemistry and Molecular Engineering, Beijing National Laboratory for Molecular Sciences, Peking University, Beijing, China
Yanyi Huang
School of Medicine, South China University of Technology, Guangzhou, China
Xin Jin
Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, Center for Infectious Disease Research, School of Medicine, Westlake University, Hangzhou, China
Xiangjun Chen
Research Center for Industries of the Future, Westlake University, Hangzhou, China
Xiangjun Chen
Authors
- Wenbo Sun
- Tingyu Yang
- Fengming Sun
- Panhong Liu
- Ji Gao
- Xianmei Lan
- Wei Xu
- Yuhong Pang
- Tong Li
- Cuifeng Li
- Qingtai Liang
- Haoze Chen
- Xiaohang Liu
- Wenting Tan
- Huanhuan Zhu
- Fang Wang
- Fanjun Cheng
- Weiwei Zhai
- Han-Na Kim
- Jingren Zhang
- Linqi Zhang
- Lu Lu
- Qiaoran Xi
- Guohong Deng
- Yanyi Huang
- Xin Jin
- Xiangjun Chen
- Wanli Liu
Corresponding authors
Correspondence to Lu Lu, Qiaoran Xi, Guohong Deng, Yanyi Huang, Xin Jin, Xiangjun Chen or Wanli Liu.
About this article
Cite this article
Sun, W., Yang, T., Sun, F. et al. Author Correction: An IGHG1 variant exhibits polarized prevalence and confers enhanced IgG1 antibody responses against life-threatening organisms. Nat Immunol (2026). https://doi.org/10.1038/s41590-026-02731-z
Published: 09 November 2026
Version of record: 09 November 2026
DOI: https://doi.org/10.1038/s41590-026-02731-z
来源:Nature Immunology · nature.com